Obesidad. síndrome metabólico, diabetes, dislipidemia | 07 ENE 18

Factores de riesgo cardiometabólico en niños y adolescentes

Informe clínico sobre la visión general del síndrome metabólico en niños y adolescentes
Autor/a: Sheela N. Magge, Elizabeth Goodman, Sarah C. Armstrong Pediatrics July 2017
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1. Reaven GM. Banting lecture 1988. Roleof insulin resistance in human disease. Diabetes. 1988;37(12):1595–1607

2. Meigs JB. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol. 2000;152(10):908–911

3. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol. 2002;156(11):1070–1077

4. Yip J, Facchini FS, Reaven GM. Resistance to insulin mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab.1998;83(8):2773–2776

5. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation.2004;109(3):433–438

6. Bremer AA, Mietus-Snyder M, Lustig RH. Toward a unifying hypothesis of metabolic syndrome.Pediatrics.2012;129(3):557–570

7. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation.2004;110(10):1245–1250

8. Steinberger J, Daniels SR, Eckel RH, et al; American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009;119(4):628–647

9. Zimmet P, Alberti KG, Kaufman F, et al; IDF Consensus Group. The metabolic syndrome in children and adolescents- an IDF consensus report. Pediatr Diabetes. 2007;8(5):299–306

10. Goodman E, Daniels SR, Meigs JB, Dolan LM. Instability in the diagnosis of metabolic syndrome in adolescents.Circulation. 2007;115(17):2316–2322

11. Goodman E. Metabolic syndrome and the mismeasure of risk. J Adolesc Health. 2008;42(6):538–540

12. Goodman E. Pediatric metabolic syndrome: smoke and mirrors or true magic? J Pediatr. 2006;148(2):149–151

13. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med.2003;157(8):821–827

14. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndromein American adolescents: findings from the third National Health and Nutrition Examination Survey. Circulation. 2004;110(16):2494–2497

15. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome–a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469–480

16. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Circulation. 2005;112(17):2735–2752

17. Rask-Madsen C, Kahn CR. Tissue specific insulin signaling, metabolic syndrome, and cardiovascular disease. Arterioscler Thromb Vasc Biol.2012;32(9):2052–2059

18. Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res. 2005;36(3):232–240

19. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol.2008;9(5):367–377

20. Yudkin JS. Insulin resistance and the metabolic syndrome–or the pit falls of epidemiology. Diabetologia. 2007;50(8):1576–1586

21. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell.2010;140(6):900–917

22. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med.1998;15(7):539–553

23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive  summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA.2001;285(19):2486–2497

24. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9(3):237–252

25. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome–a new worldwide definition. Lancet.2005;366(9491):1059–1062

26. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care. 2003;26(3):575–581

27. Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr. 2004;145(4):445–451

28. Duncan GE, Li SM, Zhou X-H. Prevalence and trends of a metabolic syndrome phenotype among U.S. adolescents, 1999-2000. Diabetes Care.2004;27(10):2438–2443

29. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab.2004;89(1):108–113

30. Ford ES, Li C. Defining the metabolic syndrome in children and adolescents: will the real definition please stand up? J Pediatr. 2008;152(2):160–164

31. Meigs JB, D’Agostino RB Sr, Wilson PW, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes.1997;46(10):1594–1600

32. Morrison JA, Friedman LA, Wang P, Glueck CJ. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr. 2008;152(2):201–206

33. Ventura EE, Lane CJ, Weigensberg MJ, Toledo-Corral CM, Davis JN, Goran MI. Persistence of the metabolic syndrome over 3 annual visits in overweight Hispanic children: association with progressive risk for type 2 diabetes. J Pediatr. 2009;155(4):535–541

34. Gustafson J, Easter B, Keil M, et al. Instability of the diagnosis of metabolic syndrome in children. Obesity.2007;15 (suppl): A172

35. Stanley TL, Chen ML, Goodman E. The typology of metabolic syndrome in the transition to adulthood. J Clin Endocrinol Metab. 2014;99(3):1044–1052

36. Gustafson JK, Yanoff LB, Easter BD, et al. The stability of metabolic syndrome in children and

adolescents. J Clin Endocrinol Metab.2009; 94(12):4828–4834

37. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311(8):806–814

38. Kit BK, Carroll MD, Lacher DA, Sorlie PD, De Jesus JM, Ogden C. Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010. JAMA.2012;308(6):591–600

39. Kit BK, Kuklina E, Carroll MD, Ostchega Y, Freedman DS, Ogden CL. Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012. JAMA Pediatr. 2015;169(3):272–279

40. Yu SS, Ramsey NL, Castillo DC, Ricks M, Sumner AE. Triglyceride-based screening tests fail to recognize cardiometabolic disease in African immigrant and African-American men. Metab Syndr Relat Disord.2013;11(1):15–20

41. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338(23):1650–1656

42. Kelly AS, Steinberger J, JacobsDR, Hong CP, Moran A, Sinaiko AR. Predicting cardiovascular risk in young adulthood from the metabolic syndrome, its component risk factors, and a cluster score in childhood. Int J Pediatr Obes. 2011;6(2–2):e283–e289

43. Gurka MJ, Ice CL, Sun SS, Deboer MD. A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences. Cardiovasc Diabetol. 2012;11:128

44. Goodman E, Dolan LM, Morrison JA, Daniels SR. Factor analysis of clustered cardiovascular risk sin adolescence: obesity is the predominant correlate of risk among youth. Circulation. 2005;111(15):1970–1977

45. Bao W, Srinivasan SR, Valdez R, Greenlund KJ, Wattigney WA, Berenson GS. Longitudinal changes in cardiovascular risk from childhood to young adulthood in offspring of parents with coronary artery disease: the Bogalusa Heart Study. JAMA.1997;278(21):1749–1754



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024